Effects of CYP3A5 Genotypes on Thrombocytopenia in Liver Transplantation Patients Treated with Tacrolimus

Biomedicines · 2023 · PMC10669143

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

There was no difference in the metabolizing ability for tacrolimus between the A*/GG and GG/A* groups of patients as intermediate metabolizers, although the concentration of tacrolimus appeared to be lower in patients in the GG/A* group than in those in the A*/GG group, but the apparent difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.